New research suggests that regular mammography checks play a key role in lowering the risk of death among breast cancer survivors, although their accuracy is slightly less compared to population screening. The systematic review and meta-analysis, published in 2026, indicates that using other imaging tests alongside mammography, like MRI, can help catch cancer sooner and even further reduce mortality rates.
Breast cancer is now the most commonly diagnosed cancer in women across the world, and the number of survivors continues to climb. This means more women need close monitoring after their main treatment finishes. The new review looked at 18 separate studies covering different follow-up imaging techniques, including mammography, ultrasound, MRI, and digital breast tomosynthesis.
The findings show that mammographic surveillance for survivors has a pooled sensitivity of 81%, specificity of 71%, and overall accuracy of 76%. Importantly, mammography was linked to a 50% reduction in the risk of death compared to people not having regular imaging checks. When MRIs were used, both sensitivity and specificity rates were even higher, at 91% and 82% respectively.
However, the study highlights some challenges. Accuracy in post-treatment mammography is lower than in standard screening, which often reports up to 92% accuracy. This is likely because survivors often have scarring or changes in the breast from surgery or radiation, making it harder to spot new cancers on imaging. The studies also varied in how often they did tests and how they measured mortality, making direct comparison difficult. The review mainly covers research from high-income countries, which may limit how well results apply in other places.
Despite the obstacles, experts agree on the strong benefit of mammographic follow-up. The report calls for more standardized surveillance routines across health systems to help all survivors. It also mentions that artificial intelligence might make future imaging tests even more accurate. Researchers urge further study and improvements in technology and protocols, so that everyone surviving breast cancer gets the best possible chance to stay healthy.
